Empagliflozin as a Potential Therapeutic Solution for Patients With Brugada Syndrome
Clinical trial NCT07146880 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07146880
- Sponsor
- National Taiwan University Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-15
- Primary completion
- 2027-08-21
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.